EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Characterization of Codeine Treatment Responders Among Patients with Refractory or Unexplained Chronic Cough: A Prospective Real-World Cohort Study

Ji-Yoon Oh, Sung-Yoon Kang, Noeul Kang, Ha-Kyeong Won, Eun-Jung Jo, Seung-Eun Lee, Ji-Hyang Lee, Ji-Su Shim, Young-Chan Kim, Youngsang Yoo, Jin An, Hwa Young Lee und 15 weitere

Lung · 2024-04 · 202 (2) · 97-106

DOI: 10.1007/s00408-024-00674-6 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Lung, online erschienen am 27.02.2024. Verfasst von Ji-Yoon Oh und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul,…. Hauptthemen laut MEDLINE: Codeine, Antitussive Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Merck Sharp and Dohme United Kingdom.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Codeine is a narcotic antitussive often considered for managing patients with refractory or unexplained chronic cough. This study aimed to evaluate the proportion and characteristics of patients who responded to codeine treatment in real-world practice. METHODS: Data from the Korean Chronic Cough Registry, a multicenter prospective cohort study, were analyzed. Physicians assessed the response to codeine based on the timing and degree of improvement after treatment initiation. Follow-up assessments included the Leicester Cough Questionnaire and cough severity visual analog scale at six months. In a subset of subjects, objective cough frequency was evaluated following the initiation of codeine treatment. RESULTS: Of 305 patients, 124 (40.7%) responded to treatments based on anatomic diagnostic protocols, while 181 (59.3%) remained unexplained or refractory to etiological treatments. Fifty-one subjects (16.7%) were classified as codeine treatment responders (those showing a rapid and clear response), 57 (18.7%) as partial responders, and 62 (20.3%) as non-responders. Codeine responders showed rapid improvement in objective cough frequency and severity scores within a week of the treatment. At 6 months, responders showed significantly improved scores in cough scores, compared to non-responders. Several baseline parameters were associated with a more favorable treatment response, including older age, non-productive cough, and the absence of heartburn. CONCLUSIONS: Approximately 60% of chronic cough patients in specialist clinics may require antitussive drugs. While codeine benefits some, only a limited proportion (about 20%) of patients may experience rapid and significant improvement. This underscores the urgent need for new antitussive drugs to address these unmet clinical needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CodeineAntitussive AgentsHumansProspective StudiesChronic CoughCohort StudiesCough

Stichwörter der Autor:innen

CodeineCoughReal-world studyTreatment responders

Substanzen

CodeineAntitussive Agents

Autor:innen und Institutionen

  • Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea.
  • Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
  • Division of Allergy, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Korea.
  • Department of Internal Medicine, School of Medicine, Pusan National University, Busan, Korea.
  • Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.

Förderung

  • Merck Sharp and Dohme United Kingdom

Zitieren

APA

Oh, J. Y., Kang, S. Y., Kang, N., Won, H. K., Jo, E. J., Lee, S. E., Lee, J. H., Shim, J. S., Kim, Y. C., Yoo, Y., An, J., Lee, H. Y., Park, S. Y., Kim, M. Y., Lee, J. H., Kim, B. K., Park, H. K., Kim, M. H., Kim, S. H., …, & Korean Chronic Cough Registry Study Group (2024). Characterization of Codeine Treatment Responders Among Patients with Refractory or Unexplained Chronic Cough: A Prospective Real-World Cohort Study. Lung, 202(2), 97-106. https://doi.org/10.1007/s00408-024-00674-6

Vancouver

Oh JY, Kang SY, Kang N, Won HK, Jo EJ, Lee SE, et al. Characterization of Codeine Treatment Responders Among Patients with Refractory or Unexplained Chronic Cough: A Prospective Real-World Cohort Study. Lung. 2024;202(2):97-106. doi:10.1007/s00408-024-00674-6

BibTeX
@article{Oh2024,
  author = {Oh, Ji-Yoon and Kang, Sung-Yoon and Kang, Noeul and Won, Ha-Kyeong and Jo, Eun-Jung and Lee, Seung-Eun and Lee, Ji-Hyang and Shim, Ji-Su and Kim, Young-Chan and Yoo, Youngsang and An, Jin and Lee, Hwa Young and Park, So-Young and Kim, Mi-Yeong and Lee, Ji-Ho and Kim, Byung-Keun and Park, Han-Ki and Kim, Min-Hye and Kim, Sae-Hoon and Kim, Sang-Heon and Chang, Yoon-Seok and Kim, Sang-Hoon and Lee, Byung-Jae and Chung, Kian Fan and Cho, Sang-Heon and Song, Woo-Jung and Korean Chronic Cough Registry Study Group, Korean Chronic Cough Registry Study Group},
  title = {Characterization of Codeine Treatment Responders Among Patients with Refractory or Unexplained Chronic Cough: A Prospective Real-World Cohort Study},
  journal = {Lung},
  year = {2024},
  volume = {202},
  number = {2},
  pages = {97--106},
  doi = {10.1007/s00408-024-00674-6}
}
Kostenlos starten →